Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sleep, Circadian, Hormonal Dysregulation, and Breast Cancer Survival

NCT00519168 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00519168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00519168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sleep, Circadian, Hormonal Dysregulation, and Breast Cancer Survival
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
September 30, 2006
Completion date
August 31, 2011
Enrollment
141 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer